Withdrawal: Glycine transporter 1 (GlyT1) is a novel therapeutic target for Alzheimer's disease.

Withdrawal: Miran Yoo, Seong Muk Kim, Juho Lee, Hye-Ju Kim, Seong Jeong Park. "Glycine transporter 1 (GlyT1) is a novel therapeutic target for Alzheimer's disease" Alzheimer's & Dementia, Volume 18, Supplemental Issue 10. The above abstract, published online on 20th December 2022, on Wiley Online Library (https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.064468) has been withdrawn by agreement between the authors, the Senior Director of Scientific Programs and Outreach, Claire Sexton, the Director of Scientific Programs at the Alzheimer's Association, Ozama Ismail, and John Wiley & Sons Inc. The abstract has been withdrawn at the authors' request because the authors did not have Amyloid Solution's authorization to publish the information contained in it.